Board of Directors
|
Ms. Batten is a former director of Landmark Communications, Inc., a company which operates the Weather Channel and other media and information businesses. She serves on numerous nonprofit boards, including the Amazon Conservation Association, the Peabody School and Norfolk Academy. In addition, she is actively involved at the University of Virginia with the Jefferson Scholars Foundation, the Arts Council and the Batten Institute at the Darden Graduate School of Business. Ms. Batten received her undergraduate degree from Hollins University and her M.B.A. from the University of Virginia.
Dr. Blumenfeld is President and CEO of Quescon Consultants, Ltd, a medical device consulting company as well as Founding Partner of Meditech Advisors Management, a General Partner in Ziegler Meditech Equity Partners, LP. He was an executive with General Electric for nearly 35 years and served GE Medical Systems Business in many roles, including starting the MR guided Focused Ultrasound project in 1991. Dr. Blumenfeld holds five patents and has served on an Institute of Electrical and Electronics Engineers Standards Committee, a National Cancer Institute Advisory Board, the Ontario R&D Challenge Fund Imaging Advisory Committee, a Scientific Advisory Board of the Ontario Consortium for Image-Guided Therapy and Surgery, the Imaging Research Centre for Cardiac Intervention at the University of Toronto, and on the Advisory Board of the Advanced Multimodality Image Guided Operating Suite at Harvard. He is on the Board of the Hebrew University, and serves or has served on the Boards of a number of medical device and technology companies including InSightec. Dr. Blumenfeld received his undergraduate degree and Ph.D. from the University of Toronto.
EUGENE V. FIFE Mr. Fife is the founding principal of Vawter Capital LLC, a private family office and investment company. As a former partner of Goldman Sachs, he served on the Management Committee and as chairman of Goldman Sachs International. Mr. Fife currently is a director at Office Depot, a global supplier of office products and services; at Cequel Corporation, a provider of residential and commercial cable services; and at Hamilton Sunstrand, an industrial products company. Mr. Fife was a member of the board of directors of Caterpillar from 2002-2012. During that time he served as chair of the Audit Committee, and at the time of his retirement from the board, was chair of the Governance Committee and presiding director. He was non-executive chairman of Eclipsys, a provider of healthcare information systems that merged with Allscripts in 2010. He currently is chair of the Governing Council of the Miller Center of Public Affairs, an affiliate of the University of Virginia, and he serves on the advisory board of the Duke Islamic Studies Center at Duke University. Mr. Fife received his undergraduate degree from Virginia Tech and his MBA from the University of Southern California.
Mr. Grisham is an internationally acclaimed author whose works include several #1 best sellers. Nine of his books have been made into successful motion pictures. Prior to his career as a writer, he practiced law for nearly 10 years, specializing in criminal defense and personal injury litigation. He served in the Mississippi House of Representatives from 1984 until 1990. Mr. Grisham serves on the Board of Directors for the Innocence Project, and was closely involved with establishing the “Rebuild the Coast” Fund for Gulf Coast relief in the wake of Hurricane Katrina. Mr. Grisham received his undergraduate degree from Mississippi State University and his J.D. from the University of Mississippi School of Law.
Dr. Jordan is a founding partner of Bryan and Jordan Consulting, LLC and President Emeritus of the Thomas Jefferson Foundation, which owns and operates Monticello. He is a former scholar in residence at the University of Virginia and a former professor of history at Virginia Commonwealth University. In 2009, Dr. Jordan was the James Marston Fitch Resident for Historic Preservation at the American Academy in Rome. Dr. Jordan has published three books and more than seventy articles, essays, and reviews. He is a member of the governing board of the Gilder Lehrman Institute of American History, a former Vice Chairman of the National Trust for Historic Preservation, a former Chairman of The National Park Service Advisory Board and has served on planning groups for Independence Hall, the White House, and the United States Capitol. He received his undergraduate degree from the University of Mississippi and his Ph.D. from the University of Virginia, where he was elected to Phi Beta Kappa.
Dr. Kassell is the founder and chairman of the Focused Ultrasound Foundation and a professor of neurosurgery at the University of Virginia, where he was co-chair until 2006. He has published more than 500 scientific papers and book chapters, and his research has been supported by over $30 million in NIH and industry grants and contracts. A member of numerous medical societies in the United States and abroad, he has served on many standing and ad hoc committees of the National Institutes of Health and in an editorial capacity for a variety of academic journals. Dr. Kassell is a founder of numerous private ventures including Interax, Inc., the Virginia Neurological Institute, Multimedia Medical Systems, Inc., the Neuroclinical Trials Center, the NeuroVenture Fund and MedSpecialists.net. He has served on a number of corporate and not-for-profit boards, including Eclypsis Corporation, INC Research, the Prostate Cancer Foundation, InSightec, Ltd., and Virginia National Bank, and is currently a director of the La Gesse Foundation and the Focused Ultrasound Foundation. Dr. Kassell received his undergraduate and medical education at the University of Pennsylvania. He resides with his wife and three stepchildren near Charlottesville, Virginia, and has three grown daughters and six grandchildren.
Dr. Edward D. Miller retired as CEO and chief fundraiser of John Hopkins Medicine, dean of The John Hopkins University School of Medicine and vice president for medicine of the John Hopkins University in June 2012. Dr. Miller joined John Hopkins in 1994 and was named interim dean of the school of medicine in 1996. Prior to this, Dr. Miller served at Columbia University for eight years and spent 11 years at the University of Virginia. Dr. Miller recieved his A.B. from Ohio Wesleyan University and his medical degree from the University of Rochester School of Medicine and Dentistry.
Dr. Moll is a pre-eminent leader in the development and commercialization of innovative medical devices. His start-up ventures have included Intuitive Surgical, Inc., manufacturer of the highly successful da Vinci Surgical System. He also started Origin Medsystems, Inc., a laproscopic instruments and devices company, and Endotherapeutics Corporation, manufacturer of the safety trocar, which Dr. Moll invented while training as a surgeon. He currently serves as Chairman of the Board of Hansen Medical, Inc., a soft silicone implant company he founded in 2003. Dr. Moll received his M.D. from the University of Washington and trained in surgery at Virginia Mason Hospital in Seattle. He also earned a bachelor's degree in economics from the University of California at Berkeley and a master's degree in management from Stanford University in Palo Alto, California. He is a distinguished lecturer and has authored numerous scientific articles.
Mr. Rusckowski is President and CEO of Quest Diagnostics. From November 2006-May 2012, he was the Executive Vice-President and Chief Executive Officer of Philips Healthcare and also served as a member of the Philips Board of Management. He was previously the CEO of the Imaging Systems business group of Philips Healthcare. Before joining Philips, Mr. Rusckowski held numerous management positions with the healthcare division of Hewlett-Packard/Agilent Technologies. He was the Senior Vice President and General Manager of Agilent’s Healthcare Solutions Group when Philips acquired this business in 2001. Mr. Rusckowski was born in 1957 in the United States and holds a Bachelor of Science in Mechanical Engineering from Worcester Polytechnic Institute and a Masters in management science from M.I.T.’s Sloan School of Management.
Mr. de Vink, founding Partner of Blackstone Health Care Partners, was formerly Chairman, President and Chief Executive Officer of Warner-Lambert Company and President of Schering International. He is on the Board of Directors of Roche and Flamel Technologies S.A., a member of Sotheby's International Advisory Board and a member of the European Advisory Council of Rothschild & Cie, as well as a board member of the New York Philharmonic. He received his undergraduate degrees from Nijenrode (Netherlands School of Business) and Washington University, and received his M.B.A. from American University’s Kogod School of Business.
Dr. von Eschenbach is President of Samaritan Health Initiatives, Senior Advisor with Greenleaf Health, LLC. and Senior Director for Strategic Initiatives at the Center for Health Transformation. He is the former Commissioner of the U.S. Food and Drug Administration and former Director of National Cancer Institute at the National Institutes of Health. Prior to entering public service, he had a long affiliation with the University of Texas M.D. Anderson Cancer Center, serving in numerous leadership positions, and is currently an adjunct professor at that institution. He is the former President of the American Cancer Society and was a founding member of the National Dialog on Cancer. In 2006, Time magazine named him one of the “100 most influential people to shape the world,” and he was selected in both 2007 and 2008 as one of the Modern Healthcare/Modern Physician’s “50 Most Powerful Physician Executives in Healthcare.” Dr. von Eschenbach received his undergraduate degree from St. Joseph’s University and his M.D. from Georgetown University.
|
DOROTHY BATTEN
S. MORRY BLUMENFELD, Ph.D.
JOHN GRISHAM
DANIEL P. JORDAN, Ph.D. 
NEAL F. KASSELL, M.D.
EDWARD D. MILLER, M.D.
FREDERIC H. MOLL, M.D.
STEVE RUSCKOWSKI 
LODEWIJK J.R. DE VINK
ANDREW VON ESCHENBACH, M.D.
